Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.
Open | $5.990 |
Close | $5.560 |
Volume / Avg. | 146.096K / 112.302K |
Day Range | 5.110 - 6.010 |
52 Wk Range | 2.700 - 9.970 |
Market Cap | $252.959M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 4.08% |
Days to Cover | 15.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).
The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 20.00 expecting FHTX to rise to within 12 months (a possible 236.70% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $5.94 last updated May 9, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.